## Abstract Neural transplantation, a mode of cellular replacement, has been used as a therapeutic trial for Parkinson's disease. Studies indicate that tonic release of the metabolites from the graft that can be utilized by the host brain, is likely to be the major mechanism responsible for the the
Adult stem cell therapies for neurological disorders: Benefits beyond neuronal replacement?
✍ Scribed by Cédric Boucherie; Emmanuel Hermans
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 265 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0360-4012
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The modest capacity of endogenous repair processes in the central nervous system (CNS) justifies the broad interest in the development of effective stem cell based therapies for neurodegenerative disorders and other acute or chronic lesions. Motivated by the ambitious expectation to achieve functional neuronal replacement, several studies have already evidenced a potential benefit of stem cell grafts in animal models of human disorders. Nevertheless, growing evidence suggests that the effects orchestrated by stem cells, in most experimental cases, are not necessarily associated with the generation of new neurons. This hypothesis correlates with the versatile properties of adult and embryonic stem cells. When introduced into the lesioned CNS, nondifferentiated stem cells can have a positive influence through intrinsic neuroprotective capacities related to the production of neurotrophic factors, stimulation of endogenous neurogenesis, and modulation of neuroinflammation. Stem cells are also endowed with a multipotent differentiation profile, suggesting that a positive outcome could result from the replacement of nonneuronal cell types, in particular astrocytes and oligodendrocytes. Focusing on adult stem cells, this Review aims at summarizing experimental observations supporting the concept that, in cell‐based therapies, stem cells operate not through a unidirectional mechanism (e.g., generating neurons) but rather as cellular mediators of a multitude of biological activities that could provide a favorable outcome for diverse nervous disorders. © 2008 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract It is expected that human neural stem/progenitor cells (hNS/PCs) will some day be used in cell replacement therapies. However, their availability is limited because of ethical issues, so they have to be expanded to obtain sufficient amounts for clinical application. Moreover, in‐vitro‐m